Amyloid-β Increases Activity of Proteasomes Capped with 19S and 11S Regulators

J Alzheimers Dis. 2016 Sep 6;54(2):763-76. doi: 10.3233/JAD-160491.

Abstract

Accumulation of amyloid-β (Aβ) in neurons accompanies Alzheimer's disease progression. In the cytoplasm Aβ influences activity of proteasomes, the multisubunit protein complexes that hydrolyze the majority of intracellular proteins. However, the manner in which Aβ affects the proteolytic activity of proteasomes has not been established. In this study the effect of Aβ42 and Aβ42 with isomerized Asp7 on activity of different forms of proteasomes has been analyzed. It has been shown that Aβ peptides efficiently reduce activity of the 20S proteasomes, but increase activity of the 20S proteasomes capped with the 19S and/or 11S regulators. Modulation of proteasome activity is mainly determined by the C-terminal segment of Aβ (amino acids 17-42). This study demonstrated an important role of proteasome regulators in the interplay between Aβ and the proteasomes.

Keywords: 11S regulator; 19S regulator particle; 20S proteasome; Keywords: Alzheimer’s disease; amyloid-β.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Amyloid beta-Peptides / pharmacology*
  • Cell Line, Tumor
  • Enzyme Activation / drug effects
  • Enzyme Activation / physiology
  • Humans
  • Peptide Fragments / pharmacology*
  • Proteasome Endopeptidase Complex / chemistry
  • Proteasome Endopeptidase Complex / genetics*
  • Proteasome Endopeptidase Complex / metabolism*

Substances

  • Amyloid beta-Peptides
  • Peptide Fragments
  • amyloid beta-protein (1-42)
  • PSMB11 protein, human
  • Proteasome Endopeptidase Complex